title: Frontiers of cancer care in Asia-Pacific region: cancer care in Australia.
abstract: Cancer has a significant impact on the Australian community. One in three men and one in four women will develop cancer by the age of 75. The estimated annual health expenditure due to cancer in 2000-1 in Australia was $2.7 billion, representing 5.5% of the country's total healthcare expenditure. An historical overview of the national cancer control strategies in Australia is provided. In males, the five most common cancers in order of decreasing incidence are: prostate cancer, colorectal cancer, lung cancer, melanoma and lymphoma, while for Australian women, breast cancer is the most common cancer. Key epidemiologic information about these common cancers, current management issues and comprehensive national clinical practice guidelines (where available) are highlighted. Aspects of skin cancer, a particularly common cancer in the Australian environment - with a focus on melanoma - are also included.Cancer outcomes in Australia, measured by selected outcomes, are among the best in the world. However, there is still evidence of health inequalities, especially among patients residing in regional and remote areas, the indigenous population and people from lower socio-economic classes. Limitations of current cancer care practices in Australia, including provision of oncology services, resources and other access issues, as well as suggested improvements for future cancer care, are summarised. Ongoing implementation of national and state cancer control plans and evaluation of their effectiveness will be needed to pursue the goal of optimal cancer care in Australia.
authors: Es
authors: E
authors: Koh
authors: Vt
authors: V
authors: Do
authors: Mb
authors: M
authors: Barton
references: J Clin Oncol. 2008 Jan 10;26(2):242-5
references: 18182665
references: Head Neck. 2007 Apr;29(4):387-400
references: 16358297
references: CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29
references: 14974761
references: BMC Surg. 2006 Oct 23;6:12
references: 17059598
references: Australas J Dermatol. 1999 Feb;40(1):1-5
references: 10098281
references: Lancet. 2006 Jun 3;367(9525):1842-8
references: 16753487
references: Australas Radiol. 2004 Mar;48(1):29-34
references: 15027918
references: Intern Med J. 2004 Dec;34(12):677-83
references: 15610212
references: Aust N Z J Surg. 1996 Nov;66(11):727-30
references: 8918377
references: Cancer. 2005 Sep 15;104(6):1129-37
references: 16080176
references: J Photochem Photobiol B. 2001 Oct;63(1-3):8-18
references: 11684447
references: Radiother Oncol. 2000 Nov;57(2):131-6
references: 11054516
references: Cochrane Database Syst Rev. 2002;(1):CD002200
references: 11869629
references: Br J Cancer. 2001 Sep 1;85(5):668-73
references: 11531249
references: Surg Oncol Clin N Am. 2006 Apr;15(2):301-18
references: 16632216
references: J Natl Compr Canc Netw. 2006 Aug;4(7):666-84
references: 16884669
references: IARC Sci Publ. 1999;(151):1-572
references: 10619122
references: Clin Oncol (R Coll Radiol). 2003 Apr;15(2):47-54
references: 12708710
references: Med J Aust. 2004 Jun 21;180(12):618-22
references: 15200358
references: Med J Aust. 2007 Mar 19;186(6):292-5
references: 17371209
references: N Engl J Med. 1999 Apr 29;340(17):1341-8
references: 10219070
references: Clin Cancer Res. 2007 Jul 1;13(13):3825-30
references: 17606713
references: Lancet. 2007 Jan 6;369(9555):29-36
references: 17208639
references: Surg Clin North Am. 2003 Apr;83(2):431-51
references: 12744618
references: Australas Radiol. 2002 Sep;46(3):275-9
references: 12196236
references: Lancet. 2005 Feb 19-25;365(9460):687-701
references: 15721476
references: Eur J Cancer. 2003 Jul;39(10):1439-46
references: 12826048
references: N Engl J Med. 2004 Oct 7;351(15):1502-12
references: 15470213
references: Intern Med J. 2007 Jan;37(1):18-25
references: 17199840
references: Australas Radiol. 2007 Feb;51(1):62-7
references: 17217491
references: Lancet Oncol. 2005 Nov;6(11):877-85
references: 16257796
references: Surg Oncol Clin N Am. 2007 Jan;16(1):35-54
references: 17336235